Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1691-1697

  Bernini, Giampaolo ^a   Versari, Daniele ^a   Moretti, Angelica ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Bardini, Michele ^a   Taurino, Chiara ^a   Canale, Domenico ^a   Taddei, Stefano ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; TESTOSTERONE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BODY PLETHYSMOGRAPHY; BRACHIAL ARTERY; CARDIOVASCULAR EFFECT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG TOLERANCE; FOREARM BLOOD FLOW; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; HYPOGONADISM; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

ADULT; ANDROGENS; ARTERIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FOREARM; HEMODYNAMIC PROCESSES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; REGIONAL BLOOD FLOW; TESTOSTERONE; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 33646415928     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1398     Document Type: Article

References (38)

1. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
2. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ 1998 The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1-15
3. McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ, Celermajer DS 1998 Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol 32:1331-1335
4. Herman SM, Robinson JT, McCredie RJ, Adams MR, Boyer MJ, Celermajer DS 1997 Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol 17:2004-2009
5. Wu FC, von Eckardstein A 2003 Androgens and coronary artery disease. Endocr Rev 24:183-217
6. Jones RD, Hugh Jones T, Channer KS 2004 The influence of testosterone upon vascular reactivity. Eur J Endocrinol 151:29-37
7. Liu PY, Death AK, Handelsman DJ 2003 Androgens and cardiovascular disease. Endocr Rev 24:313-340
8. Orshal JM, Khalil RA 2004 Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286:R233-R249
9. Jones RD, Pugh PJ, Jones TH, Channer KS 2003 The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br J Pharmacol 138:733-744
10. Hanke H, Lenz C, Hess B, Spindler KD, Weidemann W 2001 Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103:1382-1385
11. Larsen BA, Nordestgaard BG, Stender S, Kjeldsen K 1993 Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis 99:79-86
12. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ, Chaudhuri G 2001 Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98:3589-3593
13. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C 1999 Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819
14. Bruck B, Brehme U, Gugel N, Hanke S, Finking G, Lutz C, Benda N, Schmahl FW, Haasis R, Hanke H 1997 Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 17:2192-2199
15. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA 2002 Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87:3632-3639
16. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE 2003 Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157:25-31
17. Alexandersen P, Haarbo J, Christiansen C 1996 The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125:1-13
18. Jaffe MD 1977 Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J 39:1217-1222
19. Wu SZ, Weng XZ 1993 Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients. Chin Med J (Engl) 106:415-418
20. Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della Monica PL, Bonfigli B, Volpe M, Chierchia SL 1999 Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 99:1666-1670
21. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS 2000 Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102:1906-1911
22. Pugh PJ, Jones RD, West JN, Jones TH, Channer KS 2004 Testosterone treatment for men with chronic heart failure. Heart 90:446-447
23. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ 2001 A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86:4078-4088
24. Kenny AM, Bellantonio S, Gruman CA, Acosta RD, Prestwood KM 2002 Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 57:M321-M325
25. Zitzmann M, Brune M, Nieschlag E 2002 Vascular reactivity in hypogonadal men is reduced by androgen substitution. J Clin Endocrinol Metab 87:5030-5037
26. Sader MA, Griffiths KA, Skilton MR, Wishart SM, Handelsman DJ, Celermajer DS 2003 Physiological testosterone replacement and arterial endothelial function in men. Clin Endocrinol (Oxf) 59:62-67
27. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T 2001 Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673-2678
28. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A 1998 Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222-2229
29. Vallance P, Collier J, Moncada S 1989 Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000
30. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A 2001 Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 38:1106-1115
31. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Salvetti A 2003 Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41:1281-1286
32. Beux F, Carmassi S, Salvetti MV, Ghiadoni L, Huang Y, Taddei S, Salvetti A 2001 Automatic evaluation of arterial diameter variation from vascular echographic images. Ultrasound Med Biol 27:1621-1629
33. Ghiadoni L, Huang Y, Magagna A, Buralli S, Taddei S, Salvetti A 2001 Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens 19:547-551
34. Pedrinelli R, Taddei S, Graziadei L, Salvetti A 1986 Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension 8:786-792
35. Ong PJ, Patrizi G, Chong WC, Webb CM, Hayward CS, Collins P 2000 Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 85:269-272
36. Kang SM, Jang Y, Kim JY, Chung N, Cho SY, Chae JS, Lee JH 2002 Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am J Cardiol 89:862-864
37. Spieker LE, Sudano I, Hurlimann D, Lerch PG, Lang MG, Binggeli C, Corti R, Ruschitzka F, Luscher TF, Noll G 2002 High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 105:1399-1402
38. O'Connell BJ, Genest Jr J 2001 High-density lipoproteins and endothelial function. Circulation 104:1978-1983